Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

NCT00445003 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT00445003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
July 31, 2010
Enrollment
333 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, proliferative diabetic retinopathy